Ideas in this flowchart

• Canada's pharmaceutical and clinical-trial advantages depend on a supportive access environment.
• Canada's advantages are real.
• World-class research institutions strengthen Canada's scientific and pharmaceutical position.
• Top clinical talent contributes to Canada's attractiveness for pharmaceutical activity.
• A strong scientific base supports Canada's leadership.
• These strengths have made Canada a magnet for pharmaceutical investment.
• Canada's clinical trial ecosystem is a national advantage.
• The clinical trial ecosystem supports patients, researchers and high-skilled jobs.
• Canada's leadership depends on an access environment that encourages participation.
• A supportive access environment encourages companies to bring both clinical trials and new therapies to Canada.